Post-thrombotic syndrome secondary prevention
Jump to navigation
Jump to search
Post-thrombotic syndrome Microchapters |
Differentiating Post-thrombotic syndrome from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Post-thrombotic syndrome secondary prevention On the Web |
American Roentgen Ray Society Images of Post-thrombotic syndrome secondary prevention |
Risk calculators and risk factors for Post-thrombotic syndrome secondary prevention |
Endovascular stenting of the iliac vein may help.[1] Adding aspirin to concomitant anticoagulation did not help in a randomized controlled trial[2].
References
- ↑ Rossi, Fabio H.; Kambara, Antonio M.; Izukawa, Nilo M.; Rodrigues, Thiago O.; Rossi, Cybelle B.; Sousa, Amanda G.; Metzger, Patrick B.; Thorpe, Patricia E. (2018). "Randomized double-blinded study comparing medical treatment versus iliac vein stenting in chronic venous disease". Journal of Vascular Surgery. Venous and Lymphatic Disorders. 6 (2): 183–191. doi:10.1016/j.jvsv.2017.11.003. ISSN 2213-3348. PMID 29292114.
- ↑ Barco, Stefano; Jalaie, Houman; Sebastian, Tim; Wolf, Simon; Fumagalli, Riccardo M.; Lichtenberg, Michael; Zeller, Thomas; Erbel, Christian; Schlager, Oliver; Kucher, Nils (2025-03-25). "Aspirin Plus Rivaroxaban Versus Rivaroxaban Alone for the Prevention of Venous Stent Thrombosis Among Patients With Post-Thrombotic Syndrome: The Multicenter, Multinational, Randomized, Open-Label ARIVA Trial". Circulation. 151 (12): 835–846. doi:10.1161/CIRCULATIONAHA.124.073050. ISSN 1524-4539. PMID 39874026 Check
|pmid=
value (help).